MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$24,837K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
License agreement revenue
0
1,039
2,711*
-
Research and development
19,391
17,903
77,694*
20,347
General and administrative
8,743
7,865
8,776*
5,538
Total operating expenses
28,134
25,768
86,470*
25,885
Other income
1,770
-
-
-
Loss from operations
-26,364
-24,729
-83,759*
-25,885
Interest income
1,527
1,446
489*
1,278
Interest expense
0
0
576*
0
Loss before provision for income taxes
-
-
-83,846*
-
Provision for income taxes
-
-
500*
-
Total other income (expense)
1,527
1,446
-
1,278
Net loss and comprehensive loss
-24,837
-23,283
-84,346
-24,607
Net loss and comprehensive loss
-24,837
-23,283
-84,346
-24,607
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
CBIO Income Statement Sankey Diagram
Sankey diagram visualizing CBIO income statement for the period
Net loss and
comprehensive loss
-$24,837K
(-13.98%↓ Y/Y)
Interest income
$1,527K
(387.86%↑ Y/Y)
Net loss and
comprehensive loss
-$24,837K
(-13.98%↓ Y/Y)
Total other income
(expense)
$1,527K
(300.92%↑ Y/Y)
Loss from operations
-$26,364K
(-25.36%↓ Y/Y)
Other income
$1,770K
Total operating
expenses
$28,134K
Research and development
$19,391K
General and
administrative
$8,743K
Buy us a coffee
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)